Americas, Asia Pacific, China, Diabetes, Drugs, India, Japan, Medical research, Mexico, Obesity, Science, Society, South and Central Asia, UK news, US news, World news
New daily weight-loss pill shows success at clinical trial
Orforglipron also reduced blood sugar levels in participants with type 2 diabetes
A significant trial of a daily weight-loss pill has found that it helped people to shed the pounds and reduce their blood sugar levels, making it a contender to join the new wave of drugs that combat obesity and diabetes.
People who took a 36mg pill of orforglipron lost an average of 7.3kg (16lbs) over nine months, according to results from a phase 3 clinical trial reported by the drug’s manufacturer, Eli Lilly, on Thursday.
＼ 最新情報をチェック ／
